To keep deciphering the role of H4R in breast cancer, in the present work, we investigated the effect of the systemic administration of the H4R agonist JNJ28 and the H4R antagonist JNJ77 in the same TNBC model developed in wild-type mice. Here, HRH4 is linked to breast cancer.